🚀 VC round data is live in beta, check it out!
Acer Medical Valuation Multiples
Discover revenue and EBITDA valuation multiples for Acer Medical and similar public comparables like Proteomics, Deepnoid, Carelabs, Data Horizon and more.
Acer Medical Overview
About Acer Medical
Acer Medical Inc focuses on improving human health and well-being through artificial intelligence. It focuses on applying artificial intelligence and large data to the area of healthcare. Acer Medical is capable of designing, developing, commercializing, as well as implementing AI solutions in medical institutions.
Founded
2018
HQ
Employees
15
Website
Financials (FY)
EV
$42M
Acer Medical Financials
Acer Medical reported last fiscal year revenue of $2M and negative EBITDA of ($890K).
In the same fiscal year, Acer Medical generated $1M in gross profit, ($890K) in EBITDA losses, and had net loss of ($929K).
Acer Medical P&L
In the most recent fiscal year, Acer Medical reported revenue of $2M and EBITDA of ($890K).
Acer Medical expects next 12-month revenue of XXX and NTM EBITDA of XXX
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue | — | XXX | $2M | XXX | XXX | XXX |
| Gross Profit | — | XXX | $1M | XXX | XXX | XXX |
| Gross Margin | — | XXX | 62% | XXX | XXX | XXX |
| EBITDA | — | XXX | ($890K) | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (47%) | XXX | XXX | XXX |
| EBIT Margin | — | XXX | (55%) | XXX | XXX | XXX |
| Net Profit | — | XXX | ($929K) | XXX | XXX | XXX |
| Net Margin | — | XXX | (49%) | XXX | XXX | XXX |
Financial data powered by Morningstar, Inc.
Acer Medical Stock Performance
Acer Medical has current market cap of $48M, and enterprise value of $42M.
Market Cap Evolution
Acer Medical's stock price is $3.13.
| EV | Market Cap | Price 1D | Price 1M | Price 3M | Price 12M | EPS |
|---|---|---|---|---|---|---|
| $42M | $48M | 0.1% | XXX | XXX | XXX | $-0.06 |
Benchmark Trading Valuation Multiples by Industry
Sign up to access valuation multiples like growth-adjusted P/E, Rule of 40, next 12-month EV/Revenue, EBITDA multiples by industry, consensus analyst estimates and many more.
Start Free TrialAcer Medical Valuation Multiples
Acer Medical trades at 22.3x EV/Revenue multiple, and (47.1x) EV/EBITDA.
Acer Medical Financial Valuation Multiples
As of April 5, 2026, Acer Medical has market cap of $48M and EV of $42M.
Equity research analysts estimate Acer Medical's 2025E EV/Revenue multiple at XXX and 2025E EV/EBITDA multiple at XXX
Acer Medical has a P/E ratio of (51.3x).
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Market cap (current) | $48M | XXX | $48M | XXX | XXX | XXX |
| EV (current) | $42M | XXX | $42M | XXX | XXX | XXX |
| EV/Revenue | — | XXX | 22.3x | XXX | XXX | XXX |
| EV/EBITDA | — | XXX | (47.1x) | XXX | XXX | XXX |
| EV/EBIT | — | XXX | (41.0x) | XXX | XXX | XXX |
| EV/Gross Profit | — | XXX | 35.7x | XXX | XXX | XXX |
| P/E | — | XXX | (51.3x) | XXX | XXX | XXX |
| EV/FCF | — | XXX | (52.1x) | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Verified Acer Medical Valuation Multiples
Access all public comps and forward-looking valuation multiples like EV/Revenue in 2027, based on consensus analyst estimates. Powered by FactSet and Morningstar.
Acer Medical Margins & Growth Rates
Acer Medical's revenue in the last fiscal year grew by 20%.
Acer Medical's revenue per employee in the last FY averaged $0.1M, while opex per employee averaged $0.1M for the same period.
Acer Medical Operational Valuation Multiples
| LTM | NTM | Last FY | FY 2026 | FY 2027 | FY 2028 | |
|---|---|---|---|---|---|---|
| Revenue Growth | — | XXX | 20% | XXX | XXX | XXX |
| EBITDA Margin | — | XXX | (47%) | XXX | XXX | XXX |
| EBITDA Growth | — | XXX | (2%) | XXX | XXX | XXX |
| Revenue per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| Opex per Employee | — | XXX | $0.1M | XXX | XXX | XXX |
| S&M Expenses to Revenue | — | XXX | 31% | XXX | XXX | XXX |
| G&A Expenses to Revenue | — | XXX | 36% | XXX | XXX | XXX |
| R&D Expenses to Revenue | — | XXX | 50% | XXX | XXX | XXX |
| Opex to Revenue | — | XXX | 117% | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc. and Morningstar, Inc.
Acer Medical Public Comps
See public comps and valuation multiples for other Health Data & Analytics comps.
| EV/Revenue | EV/EBITDA | |||||
|---|---|---|---|---|---|---|
| LTM | 2026E | 2027E | LTM | 2026E | 2027E | |
| Proteomics | XXX | XXX | XXX | XXX | XXX | XXX |
| Deepnoid | XXX | XXX | XXX | XXX | XXX | XXX |
| Carelabs | XXX | XXX | XXX | XXX | XXX | XXX |
| Data Horizon | XXX | XXX | XXX | XXX | XXX | XXX |
| DarioHealth | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
| XXXXXXXX | XXX | XXX | XXX | XXX | XXX | XXX |
Valuation data powered by FactSet, Inc.
Acer Medical M&A Activity
Acer Medical acquired XXX companies to date.
Last acquisition by Acer Medical was on XXXXXXXX, XXXXX. Acer Medical acquired XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Acquisitions by Acer Medical
| Acquired Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Get Verified M&A Valuation Multiples
Sign up to see revenue and EBITDA valuation multiples for 150K+ M&A deals.
Start Free TrialAcer Medical Investment Activity
Acer Medical invested in XXX companies to date.
Acer Medical made its latest investment on XXXXXXXX, XXXXX. Acer Medical invested in XXXXXXXX for XXX (EV/Revenue multiple of XXX).
Latest Investments by Acer Medical
| Company | Valuation | EV/Revenue | EV/EBITDA |
|---|---|---|---|
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
| XXXXXXXXXXXX | XXX | XXX | XXX |
Benchmark 350K+ Funding Rounds and Disclosed VC Valuation Multiples
Sign up to see data on 350K+ funding rounds and disclosed revenue and EBITDA valuation multiples, from seed, through growth stage, to pre-IPO.
Start Free TrialAbout Acer Medical
| When was Acer Medical founded? | Acer Medical was founded in 2018. |
| Where is Acer Medical headquartered? | Acer Medical is headquartered in Taiwan. |
| How many employees does Acer Medical have? | As of today, Acer Medical has over 15 employees. |
| Is Acer Medical publicly listed? | Yes, Acer Medical is a public company listed on Taipei Exchange. |
| What is the stock symbol of Acer Medical? | Acer Medical trades under 6857 ticker. |
| When did Acer Medical go public? | Acer Medical went public in 2022. |
| Who are competitors of Acer Medical? | Acer Medical main competitors are Proteomics, Deepnoid, Carelabs, Data Horizon. |
| What is the current market cap of Acer Medical? | Acer Medical's current market cap is $48M. |
| What is the current revenue of Acer Medical? | Acer Medical's last fiscal year revenue is $2M. |
| What is the current EV/Revenue multiple of Acer Medical? | Current revenue multiple of Acer Medical is 22.3x. |
| Is Acer Medical profitable? | No, Acer Medical is not profitable. |
Start Your
Free Trial Today
Try Multiples for free for 3 days. Got questions or need a demo? Schedule a call with us below.